| Camptothecin-binding moiety conjugates SV Govindan, DM Goldenberg, SJ Moon US Patent 7,591,994, 2009 | 195 | 2009 |
| Immunoconjugates with an intracellularly-cleavable linkage SV Govindan, SJ Moon, DM Goldenberg US Patent 7,999,083, 2011 | 187 | 2011 |
| Antibody conjugates of 7-ethyl-10-hydroxycamptothecin (SN-38) for targeted cancer chemotherapy SJ Moon, SV Govindan, TM Cardillo, CA D’Souza, HJ Hansen, ... Journal of medicinal chemistry 51 (21), 6916-6926, 2008 | 127 | 2008 |
| In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates D Jackson, J Atkinson, CI Guevara, C Zhang, V Kery, SJ Moon, C Virata, ... PloS one 9 (1), e83865, 2014 | 123 | 2014 |
| Camptothecin-binding moiety conjugates SV Govindan, DM Goldenberg, SJ Moon US Patent 8,268,317, 2012 | 115 | 2012 |
| Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites SV Govindan, SJ Moon, DM Goldenberg, CH Chang US Patent App. 11/961,436, 2008 | 91 | 2008 |
| CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates SV Govindan, TM Cardillo, SJ Moon, HJ Hansen, DM Goldenberg Clinical Cancer Research 15 (19), 6052-6061, 2009 | 85 | 2009 |
| AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody–Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AMLCD37 ADC for B/T … DS Pereira, CI Guevara, L Jin, N Mbong, A Verlinsky, SJ Hsu, H Aviña, ... Molecular cancer therapeutics 14 (7), 1650-1660, 2015 | 81 | 2015 |
| Immunoconjugates with an intracellularly-cleavable linkage SV Govindan, SJ Moon, DM Goldenberg US Patent 8,741,300, 2014 | 77 | 2014 |
| Camptothecin-binding moiety conjugates SV Govindan, DM Goldenberg, SJ Moon US Patent 8,617,558, 2013 | 75 | 2013 |
| Immunoconjugates with an intracellularly-cleavable linkage SV Govindan, SJ Moon, DM Goldenberg US Patent 8,759,496, 2014 | 71 | 2014 |
| Modulation of macropinocytosis-mediated internalization decreases ocular toxicity of antibody–drug conjugates H Zhao, J Atkinson, S Gulesserian, Z Zeng, J Nater, J Ou, P Yang, ... Cancer research 78 (8), 2115-2126, 2018 | 62 | 2018 |
| Mechanistic studies of an unprecedented enzyme-catalysed 1, 2-phosphono-migration reaction W Chang, M Dey, P Liu, SO Mansoorabadi, SJ Moon, ZK Zhao, ... Nature 496 (7443), 114-118, 2013 | 58 | 2013 |
| Determination of the Substrate Binding Mode to the Active Site Iron of (S)-2-Hydroxypropylphosphonic Acid Epoxidase Using 17O-Enriched Substrates and … F Yan, SJ Moon, P Liu, Z Zhao, JD Lipscomb, A Liu, H Liu Biochemistry 46 (44), 12628-12638, 2007 | 38 | 2007 |
| Artificial peptidase with an active site comprising a Cu (II) center and a proximal guanidinium ion. A carboxypeptidase A analogue J Suh, SJ Moon Inorganic Chemistry 40 (19), 4890-4895, 2001 | 36 | 2001 |
| Artificial trinuclear metallopeptidase synthesized by cross-linkage of a molecular bowl with a polystyrene derivative SJ Moon, JW Jeon, H Kim, MP Suh, J Suh Journal of the American Chemical Society 122 (32), 7742-7749, 2000 | 32 | 2000 |
| Immunoconjugates with an intracellularly-cleavable linkage SV Govindan, SJ Moon, DM Goldenberg US Patent 9,138,485, 2015 | 31 | 2015 |
| Purification and Characterization of the Epoxidase Catalyzing the Formation of Fosfomycin from Pseudomonas syringae JW Munos, SJ Moon, SO Mansoorabadi, W Chang, L Hong, F Yan, A Liu, ... Biochemistry 47 (33), 8726-8735, 2008 | 30 | 2008 |
| Immunoconjugates with an intracellularly-cleavable linkage SV Govindan, SJ Moon, DM Goldenberg US Patent 9,102,735, 2015 | 27 | 2015 |
| Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites SV Govindan, SJ Moon, DM Goldenberg, CH Chang US Patent 8,067,006, 2011 | 23 | 2011 |
赵宗保，Zongbao K. Zhao中国科学院大连化学物理研究所，Dalian Institute of Chemical Physics, Chinese Academy of SciencesVerified email at dicp.ac.cn
